N°1 dermatologist recommended skincare brand worldwide, La Roche-Posay’s mission is to offer life-changing dermatological skincare solutions. 
The La Roche-Posay Cancer Support program includes two pillars related to the fight against cancer: Fight With Care to improve patients’ quality of life during all cancer treatment for better adherence and higher chances of healing, and Save Your Skin to prevent skin cancer. On both topics, the brand is committed to raising awareness, training health care professional and the general public, and helping patients by supporting NGOs’ projects beyond skincare.
Recommended by 90,000 dermatologists worldwide, La Roche-Posay was created by a pharmacist in 1975 and is now present in over 60 countries. It offers a unique range of daily skincare developed for every skin type to complement their dermatological treatments and promote good skincare practices adapted to each skin concern. The brand develops formulas with its exclusive Selenium-rich water with antioxidant and soothing properties, also used at its Thermal Center, the first Dermatology Center in Europe. The products are developed using a strict formulation charter with a minimal number of ingredients and are formulated at optimal concentrations. Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety, even on sensitive skin.  

Matthew Rundle (left) receiving the Middleton Scholarship trophy from Icon Group CEO Mark Middleton

UICC is pleased to learn that its partner, Icon Group, has awarded Matthew Rundle the Middleton Scholarship for 2023 for his significant work and leadership at Icon Cancer Centre, Hobart. 

Cyclist wearing a pollution mask in central London as he commutes to work in the morning.

Israel Cancer Association (ICA) was founded in 1952. Many years of involvement and a proud record of achievement have earned ICA widespread recognition, both nationally and internationally, as a prime leader in the fight against cancer.

BHGI develops, implements and studies evidence-based, economically feasible, and culturally appropriate Guidelines for International Breast Health and Cancer Control for low- and middle-income countries (LMICs), to improve breast health outcomes and access to breast cancer screening, detection and treatment for women.

Subscribe to